Medical Devices
A full-service device agency.
We represent manufacturers, distribute to healthcare providers, and place experienced sales reps. We take the role the deal requires and we run it to a close.
Three modes of engagement
We take whichever role the deal requires.
Manufacturer representation. We carry the bag for device manufacturers in defined territories. We run clinical conversations with surgeons and proceduralists, manage value-analysis committee submissions, and own the procurement relationship through close.
Distribution to providers. For manufacturers that want capital-light expansion, we move product through our relationships with hospital systems, surgical centers, specialty practices, and group purchasing organizations.
Sales-rep recruitment and management. When a manufacturer needs to build a team, the firm sources, screens, and places experienced device reps. We can manage the team on an interim basis or build a permanent organization.
Devices and segments
Where the firm works.
We work with single-use and capital equipment across surgical, interventional, diagnostic, and outpatient segments. The firm has placed devices in hospital operating rooms, ambulatory surgical centers, specialty clinics, and imaging centers.
We do not take engagements for products that lack clinical evidence or regulatory clearance. Every account starts with a clinical and regulatory review.
Why us
Capable reps. Real relationships. Honest accounts.
Our representatives have closed device deals in the segments they cover. They know the call points, the procurement cycles, and the clinical language. Manufacturers do not pay us to train new reps on their account.
The firm tells the truth about pipeline. If an account is not going to convert, we say so and we redirect the effort. Our weekly reporting reflects real activity. It is not a pitch deck for the next renewal.
Engagement
How a deal moves.
01
Account review
We review the device, the evidence file, and the target segments. We tell you whether the firm can deliver against the stated goals.
02
Engagement build
We define territories, targets, and the model: representation, distribution, or rep placement. Economics are agreed in writing.
03
Field execution
Reps are deployed. Clinical and procurement work runs in parallel. Weekly reporting shows real activity and forecasted close dates.
04
Renewal or handoff
At the end of the engagement, the firm either renews under expanded terms or hands a built territory back to the manufacturer.
Have a deal that fits this profile.
Send a one-page brief and we will come back the same day with whether we can run it and how we would structure the engagement.